Skip to main content
. 2018 Apr 17;9:786. doi: 10.3389/fimmu.2018.00786

Figure 1.

Figure 1

Schematic view of exploiting Tregs for the treatment of SLEIL-2 expands both tTreg/nTreg and pTreg including tissue Treg. Rapamycin and CaMK4 inhibitor facilitate the differentiation of Treg and inhibit TH17. Rapamycin can also stabilize the Treg function. tTreg, thymic regulatory T-cells; nTreg, naïve Treg; pTreg, peripheral Treg; TH17, IL-17-producing helper T-cells.